Influence of variants of Fcg receptor IIA on the European league against rheumatism responses to anti-tumour necrosis factor alpha therapy in psoriatic arthritis
[摘要]
[发布日期] 2010-11-25 [发布机构]
[效力级别] [学科分类]
[关键词] Infliximab;Etanercept;Adalimumab;Psoriatic Arthritis;EULAR Response [时效性]
